CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $489,000 | -26.2% | 19,402 | -18.5% | 0.01% | -15.4% |
| Q1 2015 | $663,000 | +52.8% | 23,802 | 0.0% | 0.01% | +62.5% |
| Q4 2014 | $434,000 | -49.8% | 23,802 | -64.3% | 0.01% | -46.7% |
| Q3 2014 | $865,000 | -13.8% | 66,732 | +8.6% | 0.02% | -6.2% |
| Q2 2014 | $1,003,000 | +277.1% | 61,442 | +307.7% | 0.02% | +300.0% |
| Q1 2014 | $266,000 | -57.0% | 15,072 | -40.9% | 0.00% | -63.6% |
| Q4 2013 | $618,000 | – | 25,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |